Thomas John Dietz's Net Worth

-$175 Thousand

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Thomas John Dietz?

Thomas John Dietz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LEAP THERAPEUTICS, INC., Eiger BioPharmaceuticals, Inc., and Transcept Pharmaceuticals Inc.

SEC CIK

Thomas John Dietz's CIK is 0001574218

Past Insider Trading and Trends

2020 was Thomas John Dietz's most active year for acquiring shares with 9 total transactions. Thomas John Dietz's most active month to acquire stocks was the month of February. 2023 was Thomas John Dietz's most active year for disposing of shares, totalling 9 transactions. Thomas John Dietz's most active month to dispose stocks was the month of August. 2018 saw Thomas John Dietz paying a total of $106,200.00 for 43,750 shares, this is the most they've acquired in one year. In 2018 Thomas John Dietz cashed out on 11,430 shares for a total of $76,605.30, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LEAP THERAPEUTICS, INC. (LPTX) Snapshot price: $2.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Aug 23
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Sep 1
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Aug 10
Form 4
—
0
—
—
0
Apr 9
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Apr 18
Form 4
—
0
—
—
0
Jan 23
Form 3
—
0
—
—
0
No matching records found

Eiger BioPharmaceuticals, Inc. (EIGR) No price found

Investor

Thomas John Dietz owns 21,000 units of Common Stock. In the year 2016 Thomas John Dietz filed a total of 19 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
∞
50K
$1.43
$71,580.00
50K
Jan 23
Form 4
-51.72%
-22.50K
$1.17
-$26,302.50
21K
Dec 22
Form 4
+16.00%
6K
—
—
43.5K
Mar 11
Form 4
+7.14%
2.5K
$8.49
$21,220.00
37.5K
Apr 9
Form 4
+16.67%
5K
—
—
35K
Mar 12
Form 4
+3.45%
1K
$4.95
$4,950.00
30K
Mar 16
Form 4
+20.83%
5K
—
—
29K
Mar 12
Form 4
+20.00%
4K
$13.94
$55,760.00
24K
Jan 10
Form 4
+33.33%
5K
$11.10
$55,495.00
20K
Apr 23
Form 4
+50.00%
5K
$11.05
$55,250.00
15K
Apr 22
Form 4
—
0
—
—
0
Mar 21
Form 4
+100.00%
5K
$9.98
$49,900.00
10K
Dec 20
Form 4
∞
5K
$11.26
$56,300.00
5K
Dec 6
Form 4
—
0
—
—
0
Mar 14
Form 4
—
0
—
—
0
Apr 12
Form 4/A
—
0
—
—
0
Mar 28
Form 4
—
0
—
—
0
Mar 28
Form 3
—
0
—
—
0
No matching records found

Transcept Pharmaceuticals Inc No price found

Investor

Thomas John Dietz used to own units in Common Stock but no longer holds any shares there. In the year 2013 Thomas John Dietz filed a total of 17 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-69.25K
—
—
0
Sep 21
Form 4
+40.00%
20K
—
—
70K
Feb 8
Form 4
+66.67%
20K
—
—
50K
Feb 16
Form 4
+42.86%
9K
—
—
30K
Feb 18
Form 4
+75.00%
9K
—
—
21K
Feb 19
Form 4
+166.67%
7.5K
—
—
12K
Feb 26
Form 4
-40.00%
-3.00K
$7.14
-$21,420.00
4.5K
Scheduled
Feb 15
Form 4
-55.44%
-9.33K
$5.01
-$46,743.30
7.5K
Dec 21
Form 4
+80.39%
7.5K
—
—
16.83K
Feb 14
Form 4
-18.37%
-2.10K
$14.22
-$29,862.00
9.33K
Scheduled
Feb 5
Form 4
+110.50%
6K
—
—
11.43K
Feb 2
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Feb 4
Form 4
∞
5.43K
—
—
5.43K
Oct 30
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Apr 10
Form 3
—
0
—
—
0
No matching records found